NYBCe and CZ Biohub will derive iPSC lines from cord blood's immune cells, creating shared, broadly compatible resources for cell therapy, disease modelling, and AI-driven drug development.

Aplastic anemia is a rare, life-threatening blood disorder where patients are unable to make enough blood cells due to the ...

Blood centers are scaling cell and gene therapies by leveraging decades of expertise in apheresis, logistics, and quality ...

About 100,000 Americans have sickle cell disease (SCD), the most common inherited blood disorder in the US. Roughly 10% of ...

A stem cell donor drive at Ozarks Community Hospital in Gravette gave people the chance to join a donor registry with a ...

Red blood cells modified with Nobel-prizewinning chemistry can snap together to form clots that staunch bleeding in seconds.

Scientist Elizabeth Ng is clutching a small flask with a clear mixture inside it that she’s just retrieved from inside a ...

GRAVETTE, Ark. — A stem cell donor drive at Ozarks Community Hospital in Gravette gave people the chance to join a donor ...

Sickle cell disease (SCD) is the most common inherited blood disorder in the United States. Approximately 10% of people with ...

Huntsville Hospital is expanding care options for patients with blood disorders, launching a new outpatient red blood cell ...

We also report on a new use for artificial intelligence that could help eliminate some racial inequities in heart disease ...

The first clinical trial to test the tumour-fighting power of a stem-cell-like class of long-lived immune cells suggests that ...